Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Long-term results and prognostic factors in patients with differentiated thyroid carcinoma
1985461 citationsMaurice Tubiana, Martin Schlumberger et al.Cancerprofile →
Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer
2012448 citationsMartin Schlumberger, E Benhamou et al.profile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of E Benhamou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Benhamou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Benhamou more than expected).
This network shows the impact of papers produced by E Benhamou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Benhamou. The network helps show where E Benhamou may publish in the future.
Co-authorship network of co-authors of E Benhamou
This figure shows the co-authorship network connecting the top 25 collaborators of E Benhamou.
A scholar is included among the top collaborators of E Benhamou based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with E Benhamou. E Benhamou is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Benhamou, E, et al.. (2003). [Spectacular response to cortisone therapy in acute thrombocytopenic purpura with auto-antibodies].. PubMed. 70(19-20). 684–90.
Valteau-Couanet, D, Gilles Vassal, Corinne Pondarré, et al.. (1996). Phase I study of high-dose continuous intravenous infusion of VP-16 in combination with high-dose melphalan followed by autologous bone marrow transplantation in children with stage IV neuroblastoma.. PubMed. 17(4). 485–9.5 indexed citations
10.
Estève, Jacques, E Benhamou, & L. Raymond. (1994). Statistical methods in cancer research. Volume IV. Descriptive epidemiology.. PubMed. 1–302.395 indexed citations
Laplanche, A. & E Benhamou. (1991). [Estimation of cancer incidence in France].. PubMed. 78(5). 405–14.8 indexed citations
14.
Brugières, Laurence, et al.. (1988). [Hepatic complications after high-dose chemotherapy and bone marrow autograft in solid tumors in children].. PubMed. 17(25). 1305–8.2 indexed citations
15.
Hartmann, Olivier, C Kalifa, F. Beaujean, et al.. (1985). Treatment of advanced neuroblastoma with two consecutive high-dose chemotherapy regimens and ABMT.. PubMed. 175. 565–8.8 indexed citations
16.
Clavel, Françoise, E Benhamou, Régine Sitruk‐Ware, P Mauvais-Jarvis, & R Flamant. (1985). Breast cancer and oral contraceptives: A review. Contraception. 32(6). 553–569.7 indexed citations
17.
Tubiana, Maurice, Martin Schlumberger, Philippe Rougier, et al.. (1985). Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer. 55(4). 794–804.461 indexed citations breakdown →
18.
Sancho-Garnier, H, et al.. (1984). An example of a pragmatic trial in the treatment of basocellular carcinoma of the skin.. PubMed. 32(3-4). 249–53.1 indexed citations
Benhamou, E & Marc‐Olivier Timsit. (1956). [Polyneuritis of isoniazide].. PubMed. 64(10). 199–202.2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.